Many of the most serious human diseases have an origin, at least in part, in the genome. The ability to identify and characterize genomic changes underlying genetic-based diseases offers tremendous hope for transforming health care. As part of Columbia University's overall Precision Medicine Initiative, the IGM collaborates with clinical departments to provide comprehensive interpretation of patient genomes and acts as a permanent resource for New York-Presbyterian clinicians to make effective use of genomic data to improve patient care.
To this end, the IGM is targeting its efforts in therapeutic areas where genomic data is expected to provide important clinical impact. These areas include: